Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-03-30

Clinical Trial Update: PErsonalized Addition of Recombinant LH in Ovarian Stimulation [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating personalized addition of recombinant LH in ovarian stimulation for infertility; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Luveris (lutropin alfa)

Snippet

Sponsor: Fundación Santiago Dexeus Font | Conditions: Infertility | Phase 4 | Status: RECRUITING